Gapping up
In reaction to earnings/guidance:
- TRUP +15.1% (also AFL and TRUP announce pet insurance alliance; AFL to take 9% stake in TRUP), MHK +13.1%, PDM +12.7%, PLT +12.7%, ACHC +12.1%, ZEN +11.3%, RMD +9.7%, FIVN +9%, SPXC +8.9%, FLEX +8.8%, UAA +7.3% (also sells the MyFitnessPal platform to Francisco Partners in transaction valued at $345 mln) ITT +7%, NWL +7%, MGI +6.9%, NTUS +6.2%, GOOG +6%, CACC +5.9%, PVG +4.9%, CVNA +4%, MX +3.9%, SKYW +3.7%, RBBN +3.6%, CBOE +3.5%, SM +3.4%, UHS +3.4%, CHE +3.4%, ASX +3.4%, AX +3.3%, ATUS +3.2%, KTOS +3.2%, EVTC +3.1%, FWRD +3%, DECK +2.8%, CL +2.3%, MSI +2.2%, ACGL +1.8%, FLIR +1.8%, WW +1.7%, LEA +1.7%, BAH +1.7%, PBI +1.6%, CWST +1.5%, DVA +1.4%, WY +1.4%, BR +1.4%, TOT +1.3%, HTGC +1.2%, KKR +1.2%, AUY +1.1%, MO +1.1%, PSXP +1%, CAKE +0.9%
Other news:
- EQ +29% (receives Study May Proceed letter from the FDA for itolizumab in COVID-19 patients)
- ATRO +4.8% (Astronics and Xenex Disinfection Services announced Xenex has awarded a $20 million contract to Astronics to assist in the manufacturing of Xenex's unique LightStrike Germ-Zapping Robots)
- BLDP +4.2% (signs deal with AUDI AG regarding use of fuel cell stack for vehicle propulsion)
- PKI +0.9% (COVID-19 test kit receives FDA EUA for sample pooling)
Analyst comments:
- RDS.A +2% (upgraded to Equal Weight from Underweight at Barclays)
- PZZA +1.8% (upgraded to Outperform from Perform at Oppenheimer)
- ANET +1.6% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
- CAKE +0.9% (upgraded to Buy from Hold at Gordon Haskett)
- NOK +0.9% (upgraded to Neutral from Underperform at Exane BNP Paribas)